BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22143469)

  • 1. Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician.
    Rice L
    Methodist Debakey Cardiovasc J; 2011; 7(4):6-9. PubMed ID: 22143469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-induced thrombocytopaenia.
    Gounden R; Blockman M
    Cardiovasc J Afr; 2008; 19(6):325-7. PubMed ID: 19104731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.
    Arepally GM; Padmanabhan A
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):141-152. PubMed ID: 33267665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
    Demma LJ; Paciullo CA; Levy JH
    J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
    Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
    Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The identification and management of heparin-induced thrombocytopenia in the vascular patient.
    LaMuraglia GM; Houbballah R; Laposata M
    J Vasc Surg; 2012 Feb; 55(2):562-70. PubMed ID: 22188737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia and thrombosis.
    Arepally G; Cines DB
    Clin Rev Allergy Immunol; 1998; 16(3):237-47. PubMed ID: 9773251
    [No Abstract]   [Full Text] [Related]  

  • 9. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D; Taylor M
    Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: diagnosis and management.
    Liebman HA
    Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rivaroxaban for treatment of heparin-induced thrombocytopenia after cardiac surgery: A case report.
    Abouchakra L; Khabbaz Z; Abouassi S; Badaoui G
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):e19-20. PubMed ID: 26055438
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
    Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
    Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopenia.
    Zoller M; Atmowihardjo I; Huch J; Albrecht I; Habedank D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):624. PubMed ID: 34972517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia with thrombosis syndrome managed with plasmapheresis.
    Kramer R; Oberg-Higgins P; Russo L; Braxton JH
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):439-41. PubMed ID: 19129243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
    Bream-Rouwenhorst HR; Hobbs RA
    Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH; Isaacs A
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
    Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
    Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.